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The 60,000-molecular-weight cysteine-rich outer membrane protein (OMP2) from Chiamydia trachomatis
participates in the disulfide-mediated outer-membrane organization unique to this organism. In addition, this
protein is a primary focus of the host immune response. We cloned and sequenced the gene for OMP2 from C.
trachomatis serovar L2. A Agtll recombinant that expressed an antigenic portion of this protein was selected
by antibody screening and provided a probe for the selection in A1059 of a clone containing the entire gene.
DNA sequencing of this clone identified one open reading frame of 1,641 base pairs, starting with a methionine
codon and coding for a polypeptide with a molecular weight of 58,792. Amino-terminal protein sequencing and
analysis of the translated DNA sequence demonstrated that processing at alternate signal peptide cleavage sites
accounts for the molecular-weight polymorphism of this protein. The mature proteins had a net positive charge
and contained 24 cysteine residues.
Infections by Chlamydia trachomatis are a leading cause
of sexually transmitted disease, infertility, and blindness.
Within the species, two biovars have been described which
are responsible for human disease (19). The trachoma biovar
infects mucosal epithelial cells and produces localized infec-
tion of the urogenital tract and eyes. The lymphogranuloma
venereum (LGV) biovar has broader host cell specificity and
causes more invasive sexually transmitted disease. Chla-
mydiae have a unique life cycle in which the bacteria
alternate between two developmental forms, the extracellu-
lar elementary body (EB) and the intracellular reticulate
body. Only the EB is capable of extracellular survival, host
cell recognition, and invasion, suggesting a fundamental role
for EB outer membrane constituents in infectivity.
The differences in infectivity observed between the tra-
choma and LGV biovars may be mediated by dissimilarity in
outer membrane composition, variation in primary structure
of the EB constituents, or higher-ordered structural hetero-
geneity. The EB outer membrane contains three cysteine-
rich proteins with molecular weights of about 40,000
(MOMP), 60,000 (OMP2), and 15,000. The chlamydial cell
envelope lacks a peptidoglycan layer for structural integrity
(2). It has been proposed that in its absence inter- and
intramolecular disulfide bonding among the cysteine-rich
proteins imparts rigidity to the EB outer membrane (22).
Complete sequence information for the MOMP-encoding
genes of several serotypes (25, 26) indicates that this protein
is antigenically complex, possessing species-, subspecies-
and serovar-specific epitopes on each molecule (28). The
15,000-molecular-weight cysteine-rich protein has recently
been described as possessing both biovar- and species-
specific epitopes (31). To date, the epitopes identified on the
60,000-molecular-weight outer-membrane protein by mono-
clonal antibodies have all been species specific, demonstrat-
ing less antigenic diversity than the other cysteine-rich
proteins (20).
* Corresponding author.
Despite the evidence for a shared antigenic structure,
there are several striking physical differences between the
60,000-molecular-weight proteins of the trachoma biovar and
the more invasive LGV biovar. This protein appears as a
predominant single band in gel electrophoresis of trachoma
strains but is present as a less intense doublet in LGV strains
(3). Recently, peptide maps have demonstrated that there
are significant structural differences between the proteins of
these two biovars (20). Further, it has been observed that the
60,000-molecular-weight protein of the trachoma biovar has
a nearly neutral isoelectric point (pl), whereas the LGV
proteins have a net positive charge, with a pl of 8.5 to 9.0 (3).
Batteiger et al. (3) have proposed that the relative ease with
which LGV strains attach to negatively charged host cells
may be aided by this protein. Although a role for this protein
in attachment or invasion of host cells has not been eluci-
dated, the physical differences observed between the two
biovars in this essential structural protein suggest that it
functions as a virulence determinant.
To define the structure, antigenicity, and other potential
functions of the 60,000-molecular-weight protein, we iso-
lated and sequenced the gene for this protein from serovar
L2 (LGV biovar). In this study, we refer to the 60,000-
molecular-weight outer membrane protein as OMP2 because
it is the second most abundant outer membrane protein by
Coomassie staining. Although, this nomenclature does not
include reference to the cysteine-rich nature of this protein,
it is appropriate in relation to the MOMP, which is also a
relatively cysteine-rich protein (10, 25). The gene for OMP2
from serovar L2 was designated omp2L2. omp2L2 consisted
of a 1,641-base-pair (bp) open reading frame which encodes
547 amino acids. The translated amino acid sequence re-
vealed a relatively basic protein containing 24 cysteine
residues. Amino-terminal protein sequencing and sequence
analysis demonstrated that posttranslational cleavage of a
leader peptide occurs at two different sites and results in
mature proteins of 54,533 and 56,677 daltons.
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MATERIALS AND METHODS
Bacterial strains. C. trachomatis L2/434/Bu, B/TW5/OT,
C/TW3/OT, F/UW6/Cx and I/UW-12/Ur have been previ-
ously described (15), as has the Xgt11 bacteriophage recom-
binant from serovar L2 designated gtll/L2/46 (24). Bacterio-
phage X1059, its host Escherichia coli Q359 (12), and the
pUC plasmids and M13 phage systems, have been previ-
ously described (18).
Antiserum production. The ,-galactosidase fusion peptide
from the induced lysogen of gtll/L2/46 was fractionated by
bacterial cell lysis in 1% Zwittergent (Calbiochem-Behring),
followed by centrifugation through 20% sucrose at 20,000 x
g. A rabbit was immunized with about 20 ,g of the fraction-
ated protein subcutaneously with Freund complete adjuvant.
The rabbit was boosted intravenously with about 10 pig of
the protein 14 and 21 days after the first immunization.
Antiserum was collected 10 days after the last immunization.
Immunoblot analysis. EBs were harvested and Renografin
(E. R. Squibb & Sons) purified as previously described (15).
Outer membranes were prepared by treatment of EBs with
sarcosyl as described by Caldwell et al. (7). Sarcosyl-
insoluble pellets were placed in sodium dodecyl sulfate
sample buffer containing P-mercaptoethanol, loaded onto
polyacrylamide gels, electrophoresed, transferred, and
probed by standard methods (24). The rabbit antiserum
described above was used as the primary antibody at a
dilution of 1/1,QOO, followed by horse radish peroxidase-
conjugated goat anti-rabbit immunoglobulin G (Zymed Labs,
Inc.). The chromogen 4-chloro-1-naphthol (Sigma Chemical
Co.) was used to detect antibody binding as previously
described (24).
Characterization of gtll/L2/46 DNA. DNA was isolated
from the recombinant bacteriophage as previously described
(16). The insert DNA was identified by digestion of bacte-
riophage DNA with EcoRI and separation on agarose gels.
The location of the chlamydial DNA insert relative to lacZ
was determined by restriction endonuclease analysis with
SstI, KpnI, and EcoRI. An 870-bp EcoRI chlamydial insert
from gtll/L2/46 was subcloned into pUC18 and designated
J702. Standard methods were used for enzyme analysis and
pUC cloning (16).
Construction of genomic libraries for C. trachomatis serovar
L2. DNA from C. trachomatis L2/434/Bu was isolated as
previously described (24). Standard procedures were used
for enzymatic reactions and for isolation of phage DNA (16).
Chlamydial genomic DNA was partially digested with
Sau3A. The Saq3A fragments were ligated to BamHI-di-
gested X1059 DNA and packaged into phage by using com-
mercially prepared extracts (Amersham Corp.). Recombi-
nant phage were plated on Q359 for screening (12).
Selection and analysis of X1059 recombinant phage. The
chlamydial insert DNA from J702 was purified by extraction
from low-melting-point agarose and labeled with 32P. Label-
ing was performed by the random-primer method with
commercially prepared reagents (Bethesda Research Labo-
ratories, Inc.). Phage were plated in E. coli Q359 at densities
of about 103 PFU/150-mm-diameter plate and screened with
the 32P-labeled insert DNA as previously described (25).
Plaques that produced strong signals were picked and reas-
sayed to ensure plaque purity. DNA was isolated from the
positive clones as previously described (16). Clones were
digested with restriction endonucleases, and restriction frag-
ments of interest were identified by Southern blot analysis
(16). SstI fragments of interest were subcloned into pUC18.
Two pUC clones, R708 and R709, were mapped by restric-
FIG. 1. Immunoblot of C. trachomatis antigens; sarcosyl-soluble
and sarcosyl-insoluble (outer-membrane) preparations of serovars
L2 and C. EB lysates were probed with monospecific rabbit antise-
rum to the gtll/L2/46 f4sion peptide. Following electrophoretic
transfer of proteins from a 7.5% polyacrylamide gel to nitrocellulose
paper, the sheet was reacted with antiserum, and antibody binding
was detected with peroxidase-conjugated anti-rabbit immunoglobu-
lin and 4-chloro-1-napththol. No reactions were observed in the
lanes containing sarcosyl-soluble preparations.
tion endonuclease analysis with SstI, PstI, XbaI, Sall, and
BamHI.
DNA sequencing. DNA restriction endonuclease fragments
to be sequenced were cloned into M13mpl8 and M13mpl9.
The M13 clones were sequenced by the dideoxy-chain
termination method by using commercially available re-
agents (Sequenase; United States Biochemical). When re-
quired, oligonucleotide probes were prepared in an auto-
mated synthesizer (Biosearch 8600) and used to continue
sequencing. In addition, the Agtll EcoRI site forward primer
(New England BioLabs) was used for sequencing of a
fragment containing Xgtll DNA upstream of the EcoRI
cloning site. All sequences were confirmed by sequencing of
the complementary strand.
Protein sequencing. Outer membranes of chlamydial EBs
were prepared by treatment with sarcosyl as described by
Caldwell et al. (7). Sarcosyl-insoluble pellets were placed in
sodium dodecyl sulfate sample buffer containing P-mercap-
toethanol, separated on 7.5% polyacrylamide gels, trans-
ferred to a membrane (Immobilon; Millipore Corp.), stained
with Coomassie brilliant blue, and destained, and the bands
were cut out with a razor blade as described by Matsudaira
(17). Samples were sent to the Louisiana State University
Bio Technologies Unit for sequencing on a pulsed-liquid
protein microsequencer (Applied Biosystems model 477A).
Amino acid residues were determined from values in the 5-
to 10-pmol range.
RESULTS
Characterization of gtll/L2/46. Antiserum to the recombi-
nant bacteriophage gtll/L2/46 (24) was used to probe immu-
noblots of serovar L2 EB lysates. Two bands with relative
mobilities of 56,000 and 58,000 were observed (Fig. 1). Upon
fractionation, it was revealed that this antiserum reacted
only with the outer membrane (sarcosyl insoluble) of chla-
mydial EBs. While two bands were observed with serovar
L2, the antiserum reacted with only a single 57,000-molecu-
lar-weight species in trachoma serovars C and F (Fig. 1; only
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FIG. 2. Restriction endonuclease map of the gtll/L2/46 recombinant clone (top) and the 3.5- and 2.7-kb SstI fragments obtained from a
X1059 recombinant (bottom). The sequencing strategy is shown by arrows. The solid box represents the omp2 open reading frame. Open
boxes represent Xgtll vector DNA.
servar C is shown). The fusion peptide from gtll/L2/46 was
reactive by immunoblot with one of three monoclonal anti-
bodies that bind distinct epitopes on OMP2 (W. J. Newhall,
personal communication). From these data, we concluded
that the fusion peptide from this recombinant represents an
antigenic portion of the 60,000-molecular-weight outer mem-
brane protein described by several investigators (3, 10, 21).
The fusion peptide had a molecular weight of about
146,000 by polyacrylamide gel electrophoresis, suggesting
that the chlamydial DNA insert encodes for a polypeptide
with a molecular weight of about 30,000. DNA prepared
from gtll/L2/46 was mapped with KpnI, SstI, and EcoRI.
An 870-bp EcoRI insert adjacent to lacZ was identified (Fig.
2).
The 870-bp fragment was cloned into M13mp18 and
M13mpl9 and sequenced. The sequence revealed only one
significant open reading frame, which spanned the entire
sequence. In addition, a 1.4-kilobase (kb) SstI fragment from
gtll/L2/46 (Fig. 2) was cloned into M13mpl9. This fragment
included a portion of the ,-galactosidase gene upstream of
the cloning site in addition to the insert DNA. This allowed
use of the Agtll forward primer, which hybridizes to lacZ 13
nucleotides upstream of the EcoRI cloning site. A sequence
obtained from this clone confirmed that the 870-bp EcoRI
fragment was adjacent to and in frame with lacZ. The
molecular weight of the translated open reading frame was
30,416, consistent with that of the protein product. The
sequence of this insert DNA is described below with the
entire gene sequence.
Selection and analysis of genomic recombinants. The 870-bp
chlamydial DNA insert from gtll/L2/46 was used to select
recombinants from a X1059 genomic library of serovar L2.
An SstI site had been identified within the gene for OMP2 by
mapping of the gtll/L2/46 DNA. Thus, the DNA prepared
from these X1059 recombinants was digested with SstI and
evaluated by Southern hybridization. The presence of two
bands (2.7 and 3.5 kb) which hybridized to the probe
demonstrated that the X1059 clones contained the entire gene
(data not shown). Both SstI fragments were subcloned into
pUC18 and mapped (Fig. 2). Restriction sites within the
870-bp fragment and within the two SstI fragments allowed
orientation of the 3.5-kb fragment 5' to the 2.7-kb fragment.
Restriction endonuclease digests of C. trachomatis DNA
obtained from serovar L2 were probed by Southern hybrid-
ization with the gtll/L2/46 chlamydial DNA insert. The
probe hybridized to a single restriction fragment in XbaI,
BamHI, and HindIlI digests while hybridizing to two bands
in SstI digests (data not shown), indicating the presence of a
single gene for OMP2. Southern hybridization was also
performed on BamHI and HindlIl digests of DNA obtained
from serovar I. Bands were detected which closely migrated
with analogous bands from digests of LGV biovar DNA (Fig.
3). This shows that omp2 genes for trachoma and LGV
biovars are in similar genomic contexts. Thus, gene differ-
ences which could account for the physical and structural
differences observed in this protein are localized within a
common gene framework.
Gene sequence. The sequencing strategy for omp2L2 is
shown in Fig. 2. The sequence revealed one long open
reading frame of 1,641 bp which started with a methionine
Hindill BaniHl
I L2 I L2
FIG. 3. Southern blot of HindIlI- and BamHI-digested genomic
DNAs obtained from C. trachomatis serovars L2 and I probed with
a 32P-labeled 870-bp gtll/L2/46 insert.
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AGATGTAGTTAGTAAGGAAGTTGGCTTCCTTACTAACTATTTCGGCTTAACAAGAAAAATGTTGAGGGTAAAAGTTAGTTAATAACAATTTCTACCCGA
TGGGCAGACAAAAAATAATCTAGCGAATAGGAGATC
(1)
Ser Val Ala Ser Leu Phe Ala Ser Gly
AGT GTG GCG AGT TTA TTT GCT AGC GGG
1
Leu Ala Asp Thr Lys Ala Lys Asp Asn
TTA GCT GAC ACC AAA GCG AAA GAC AAC
Pro Val Asn Arg Lys Lys Val Ala Pro
CCC GTA AAC CGT AAA AAG GTT GCT CCG
Arg Met Tyr Thr Val Lys Val Asn Asp
AGA ATG TAT ACA GTC AAA GTT AAT GAT
Gly Ser Pro Tyr Pro Val Glu Ile Thr
GGA TCT CCC TAT CCT GTT GAA ATT ACT
Pro Cys Glu Ala Glu Phe Val Arg Ser
CCA TGT GAA GCA GAG TTC GTA CGC AGT
Asp Arg Leu Gly Gln Gly Glu Lys Ser
GAC CGC TTA GGA CAA GGC GAA AAG AGT
Ala Ala Thr Val Cys Ala Cys Pro Glu
GCT GCA ACA GTA TGC GCT TGT CCA GAG
Glu Gly Pro Glu Asn Ala Cys Leu Arg
GAA GGC CCA GAG AAT GCT TGT TTG CGT
Ala Arg Asn Val Val Val Glu Asn Pro
GCT CGT AAC GTT GTT GTT GAA AAT CCT
Thr Leu Gly Asp Met Gln Pro Gly Glu
ACT CTT GGA GAT ATG CAA CCT GGA GAG
Thr Asn Ile Ala Met Val Ser Tyr Cys
ACC AAT ATA GCA ATG GTT TCT TAC TGT
Cys Val Gln Val Ser Ile Ala Gly Ala
TGC GTA CAA GTA AGT ATT GCA GGA GCA
Asn Pro Gly Asp Leu Val Leu Arg Asp
AAT CCT GGA GAT CTT GTG TTG CGA GAT
Ala Gly Ala Gln Ile Ser Cys Asn Lys
GCA GGA GCT CAA ATT TCT TGT AAT AAA
Lys Val Leu Val Arg Ala Gln Thr Pro
AAA GTT CTA GTA AGA GCA CAA ACT CCT
Thr Cys Thr Ser Cys Ala Glu Ala Thr
ACT TGT ACT TCT TGC GCA GAA GCG ACA
Cys Asp Pro Val Cys Val Gly Glu Asn
TGT GAC CCT GTT TGT GTA GGA GAA AAT
Asn Val Ser Leu Met Leu Lys Phe Ser
AAT GTT TCT TTA ATG CTT AAA TTC TCT
Thr Gly Asn Thr Val Val Phe Asp Ser
ACA GGC AAT ACA GTA GTA TTC GAT TCG
Lys Ala Val Ser Ala Gly Asp Ala Arg
AAA GCA GTA TCA GCT GGA GAT GCT CGT
Thr Glu Asn Thr His
ACA GAG AAT ACA CAC
Met Asn Lys Leu Ile Arg Arg Ala Val Thr Ile Phe Ala Val Thr
'CT ATG AAC AAA CTC ATC AGA CGA GCA GTG ACG ATC TTC GCG GTG ACT
Val Leu Glu Thr Ser Met Ala Glu Phe Ile Ser Thr Asn Val Ile Ser
GTG TTA GAG ACC TCT ATG GCA GAG TTT ATC TCT ACA AAC GTT ATT AGC
Thr Ser His Lys Ser Lys Lys Ala Arg Lys Asn His Ser Lys Glu Thr
ACT TCT CAT AAA AGC AAA AAA GCA AGA AAA AAC CAC AGC AAA GAG ACT
50
Val His Glu Ser Lys Ala Thr Gly Pro Lys Gln Asp Ser Cys Phe Gly
GTT CAT GAG TCT AAA GCT ACA GGA CCT AAA CAG GAT TCT TGC TTT GGC
Asp Arg Asn Val Glu Ile Thr Gln Ala Val Pro Lys Tyr Ala Thr Val
GAT CGT AAT GTT GAA ATC ACA CAA GCT GTT CCT AAA TAT GCT ACG GTA
100
Ala Thr Gly Lys Arg Asp Cys Val Asp Val Ile Ile Thr Gln Gln Leu
GCT ACA GGT AAA AGG GAT TGT GTT GAT GTT ATC ATT ACT CAG CAA TTA
Asp Pro Ala Thr Thr Pro Thr Ala Asp Gly Lys Leu Val Trp Lys Ile
GAT CCA GCG ACA ACT CCT ACT GCT GAT GGT AAG CTA GTT TGG AAA ATT
150
Lys Ile Thr Val Trp Val Lys Pro Leu Lys Glu Gly Cys Cys Phe Thr
AAA ATT ACT GTA TGG GTA AAA CCT CTT AAA GAA GGT TGC TGC TTT ACA
Ile Arg Ser Val Thr Lys Cys Gly Gln Pro Ala Ile Cys Val Lys Gln
ATC CGT TCG GTT ACA AAA TGT GGA CAA CCT GCT ATC TGT GTT AAA CAA
200
Cys Pro Val Val Tyr Lys Ile Asn Val Val Asn Gln Gly Thr Ala Thr
TGC CCA GTA GTT TAC AAA ATT AAT GTA GTG AAC CAA GGA ACA GCA ACA
Val Pro Asp Ser Tyr Ala His Ser Ser Gly Gln Arg Val Leu Thr Phe
GTT CCG GAT AGT TAC GCT CAT TCT TCT GGA CAG CGT GTA CTG ACG TTT
250
His Arg Thr Ile Thr Val Glu Phe Cys Pro Leu Lys Arg Gly Arg Ala
CAC AGA ACA ATT ACT GTA GAG TTT TGT CCG CTT AAA CGT GGT CGT GCT
Gly Gly His Lys Asn Thr Ala Ser Val Thr Thr Val Ile Asn Glu Pro
GGA GGA CAT AAA AAT ACA GCA AGC GTA ACA ACT GTG ATC AAC GAG CCT
300
Asp Trp Ser Tyr Val Cys Lys Pro Val Glu Tyr Val Ile Ser Val Ser
GAT TGG TCT TAT GTT TGT AAG CCT GTA GAA TAT GTG ATC TCC GTT TCC
Val Val Val Lys Asp Thr Leu Ser Pro Gly Val Thr Val Leu Glu Ala
GTC GTC GTT AAA GAC ACT CTT TCT CCC GGA GTC ACA GTT CTT GAA GCT
350
Val Val Trp Thr Val Lys Glu Leu Asn Pro Gly Glu Ser Leu Gln Tyr
GTA GTT TGG ACT GTG AAA GAA CTG AAT CCT GGA GAG TCT CTA CAG TAT
Gly Gln Phe Thr Asn Asn Val Val Val Lys Ser Cys Ser Asp Cys Gly
GGA CAA TTC ACA AAT AAT GTT GTT GTG AAG AGC TGC TCT GAC TGT GGT
400
Thr Tyr Trp Lys Gly Val Ala Ala Thr His Met Cys Val Val Asp Thr
ACT TAC TGG AAA GGA GTT GCT GCT ACT CAT ATG TGC GTA GTA GAT ACT
Thr Val Tyr Arg Ile Cys Val Thr Asn Arg Gly Ser Ala Glu Asp Thr
ACT GTT TAC CGT ATT TGT GTC ACC AAC AGA GGT TCT GCA GAA GAT ACA
450
Lys Glu Leu Gln Pro Val Ser Phe Ser Gly Pro Thr Lys Gly Thr Ile
AAA GAA CTG CAA CCT GTA TCC TTC TCT GGA CCA ACT AAA GGA ACG ATT
Leu Pro Arg Leu Gly Ser Lys Glu Thr Val Glu Phe Ser Val Thr Leu
TTA CCT AGA TTA GGT TCT AAA GAA ACT GTA GAG TTT TCT GTA ACA TTG
500
Gly Glu Ala Ile Leu Ser Ser Asp Thr Leu Thr Val Pro Val Ser Asp
GGG GAA GCG ATT CTT TCT TCC GAT ACA TTG ACT GTT CCA GTT TCT GAT
Ile Tyr STOP %- a _
ATC TAT TAA TCTTTGATTTTATCGATGTGTAGGTGCCGTCCAGGGATTCCTGGGCGGCTTTTTTTGTTATCTATAT
GAAAATAAAAGAGTTCATTTTCGTTCTCAGAGCATATTCTAGACATTTTCGTTCTCAGAGCATATTCTAGA
FIG. 4. DNA sequence and translated amino acid sequence of the omp2L2 gene, including 5' and 3' flanking sequences. The
ribosome-binding site is underlined. The N-terminal leucine of the 54,533-molecular-weight OMP2. is designated 1. The amino-terminal serine
of the 56,677-molecular-weight OMP2P is labeled with the symbol (1). The 5' and 3' dyads are shown by arrows.
codon. This open reading frame included the open reading least-free-energy value of -27.5 kcal (1 cal = 4.184 J) and
frame previously sequenced from gtll/L2/46. The open was followed by seven thymidines, which is compatible with
reading frame of omp2L2 and about 100 bp of a flanking a rho-independent terminator (23). Upstream (97 bp) of the
sequence are shown in Fig. 4. A Shine-Dalgarno ribosome- initiation codon was a 16-bp dyad (-28.5 kcal) followed by
binding sequence, AGGAG, was identified 5 bp upstream three thymidines. This is reminiscent of the gene structure of
from the initiation codon. The open reading frame was C. trachomatis ompi (27). As with the ompi sequences (26)
terminated by a single stop codon (TAA). Downstream (25 and the recently published DNA sequence for a putative C.
bp) of the stop codon was a G+C-rich 10-bp dyad. This dyad trachomatis binding protein (13), codon usage in this se-
had the potential to form a stem-and-loop structure with a quence was strongly biased toward U or A in position 3.
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Amino acid sequence. The open reading frame of the
omp2L2 gene was translated and, starting with the initial
methionine, encoded 547 amino acids (Fig. 4). The molecular
weight calculated from the amino acid sequence was 58,792.
Analysis of the translated sequence revealed several possi-
ble sites for cleavage of a leader peptide for export to the
outer membrane. To determine the amino terminus of the
mature protein, an outer membrane preparation of serovar
L2 was separated on a 7.5% polyacrylamide gel, transferred
to an Immobilon membrane, and stained with Coomassie
blue, and each band of the OMP2 doublet was excised for
microsequencing. The first 11 amino acids of each band in
the L2 doublet were determined. The sequence derived from
the lower-molecular-weight band (Leu-Ala-[Asp or Asn]-
Thr-Lys-Ala-[Lys or Leu]-X-Asn-Thr-Ser) corresponded to
amino acids 41 through 51 following the initial methionine in
the translated sequence. A sequence derived from the high-
er-molecular-weight band (X-Gly-Val-Leu-Glu-Thr-X-Met-
Ala-Glu) corresponded to amino acids 23 to 33 of the
translated open reading frame. The results revealed that the
molecular-weight polymorphism observed in LGV OMP2
was due to differences in posttranslational cleavage of the
precursor protein, yielding two different amino termini. The
547-amino-acid protein encoded by the gene can be proc-
essed at two signal sequence cleavage sites to yield either a
507-amino acid or a 525-amino-acid mature protein. Protein
gels indicate that this occurs in nearly equimolar ratios.
Molecular weights derived from translation of the omp2
open reading frame, starting at the signal cleavage sites, are
54,533 (OMP2a) and 56,677 (OMP2,). The relative mobilities
for OMP2 observed by polyacrylamide gel electrophoresis,
59,000 and 62,000 (10), may be artifactually high, since
overestimation of mass is a common feature of gel electro-
phoresis systems. The first 17 amino-terminal residues of the
trachoma serovar F mature OMP2 were determined by W. J.
Newhall (personal communication) and are identical to the
amino-terminal residues of serovar L2 OMP2a. Although a
40-amino-acid leader peptide is exceptionally long, both
OMP2L2 signal sequence cleavage sites follow the -1, -3
rule described by von Heijne (29, 30). In addition, the
cleavage site resulting in OMP2 is the same at positions - 1
and -3 (Leu-X-Ala) as that of the chlamydial MOMP leader
peptide (25), suggesting that OMP2 biovar differences are
not due to the inability of trachoma strains to cleave at that
site.
The amino acid composition of serovar L2 OMP2, as
determined by translation of the open reading frame (Table
1), included an excess of basic residues, consistent with the
basic charge observed by isoelectric focusing techniques (3).
In addition, the two glutamic acid residues present in the 18
additional amino acids of OMP2,3 account for the slightisoelectric point difference observed between the OMP2
doublet bands. The translated open reading frame consisted
of 24 cysteines (about 5%), which confirmed the cysteine-
rich nature of this protein as described by Hatch et al. (10).
Both the amino-terminal and carboxyl-terminal ends (within
about 90 amino acids) were notably lacking in cysteine
residues, and cysteine residues tend to be clustered in two
regions within the protein (Fig. 5). Of 24 cysteine residues,
15 were within four amino acid residues of a proline, and
computer-assisted secondary structure evaluation (1) re-
vealed that nearly every cysteine residue was immediately
preceded by or fell within a beta turn (data not shown). This
suggests that cysteine residues are near flexible peptide
boundaries which may be important for disulfide-mediated
membrane protein interactions.
TABLE 1. Amino acid composition of serovar L2 OMP2
Amino acid No. of
(% of total residues) residuesa
Basic (12.4)
Lys............. 38 (1)
His............. 8
Arg............. 22
Acidic (9.7)
Asp............. 24
Glu............. 29
Polar (38.0)
Asn............. 25 (2)
Cys............. 24
Gln............. 16
Gly............. 34 (1)
Ser............. 42 (6)
Thr............. 55 (4)
Tyr............. 12
Hydrophobic (39.9)
Ala............. 42 (5)
Ile............. 23 (4)
Leu............. 27 (3)
Met.;............. 7 (2)
Phe............. 13 (3)
Pro............. 29
Trp.............5
Val............. 72 (5)
a Numbers in parentheses indicate the amino acid composition of the
40-amino-acid leader peptide.
In general, OMP2 has a very even distribution of charged,
polar, and hydrophobic residues, with two exceptions. The
most notable is the positively charged, highly polar amino
terminus (residues +3 to +25) (Fig. 5). This 23-amino-acid
stretch includes 11 charged residues (mostly lysines) and is
uninterrupted by truly hydrophobic amino acids. There is
one polar but not highly charged region of 18 amino acids
(+369 to +411) within the polypeptide which overlaps the
second cluster of cysteines. No significant stretches of
hybrophobic amino acids were evident.
DISCUSSION
OMP2 of C. trachomatis functions as a key structural
component of the unique chlamydial outer membrane which,
in the absence of peptidoglycan, maintains rigidity via disul-
fide bonding of outer membrane proteins. Further, the
cysteine-rich nature of this protein and its expression late in
the developmental cycle suggest involvement in the disul-
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FIG. 5. Linear distribution of cysteine residues and charged
residues for the L2 OMP2 determined by translation of the omp2L2
gene. Each line represents one amino acid.
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fide-mediated changes that are essential for the switch be-
tween intracellular and extracellular stages of this organism
(4, 9). The antigenic significance of this protein in the host
immune response is demonstrated by studies in which the
presence of antibodies to OMP2 is consistently observed in
active infection (5, 8, 21) and is correlated with disease
status (5, 6, 11). Although no differences in antigenicity have
been observed between the OMP2s of trachoma and LGV
biovars (3, 20), significant differences in physical (20) and
chemical (3) properties of this protein between biovars have
been reported. The OMP2s of LGV and trachoma share
important and conserved structural functions; thus, dissim-
ilar properties could be related to the differences in infectiv-
ity observed between the two biovars.
EBs of the LGV biovar readily infect cell monolayers
without the assistance of centrifugation or host cell pretreat-
ment with polycations required by the trachoma biovar EBs.
The OMP2 doublet of LGV biovar strains has been shown by
Batteiger et al. (3) to have a pI of 8.5 to 9.0 as opposed to the
nearly neutral pl of the trachoma biovar OMP2. They
proposed that OMP2 may aid EB attachment to host cells by
providing a local region of positive charge and that the
difference in infectivity between biovars is due to the greater
positive charge of the LGV OMP2 than that of the trachoma
OMP2. Since the omp2 genes are highly conserved in genetic
context between the biovars and the proteins are antigeni-
cally very similar, the biovar differences observed in OMP2s
are probably localized to a defined domain(s) within the
proteins. Protein sequencing of the serovar F (trachoma
biovar) amino terminus (Newhall, personal communication)
demonstrates that these differences are not localized to this
charged region. Immunoblots with OMP2-specific antiserum
show that trachoma OMP2 migrates midway in molecular
weight between LGV OMP2,X and OMP2p, and yet the amino
terminus of trachoma OMP2 is the same as that of LGV
OMP2a. This suggests that trachoma OMP2 possesses a
highly acidic region(s), absent in LGV strains, which ac-
counts for both the molecular-weight and charge differences
observed between these otherwise identical proteins. Tra-
choma gene differences may also account for the slight size
difference observed in the BamHI restriction fragments by
Southern analysis (Fig. 3).
One of the distinctive features of the OMP2 of the LGV
biovar strains is the presence of two antigenically identical
bands which differ in molecular weight (3). Southern analysis
demonstrated that the two bands seen on protein gels were
not derived from two genes. Protein sequencing of the two
bands and analysis of the translated open reading frame
revealed that the protein is cleaved at two alternate peptide
cleavage sites, removing either a 22-amino-acid or a 40-
amino-acid leader sequence. However, the existence of
OMP2. in the outer membrane suggests that 22 amino acids
are sufficient for translocation to the outer membrane.
Therefore, cleavage may be sequential with the removal of a
22-amino-acid leader peptide from all precursors, with half
of the proteins undergoing further cleavage of 18 amino
acids. Removal of the additional 18 amino acids would
probably play a subsequent role, perhaps in assembly of
these proteins in the outer membrane.
Two-site posttranslational cleavage of a single integral
membrane protein precursor has not been described in other
procaryotes; thus, this represents a novel mechanism with
potentially important microbiological roles. This mecha-
nism, in which structural heterogeneity is derived from the
product of a single gene, may allow LGV OMP2s to exist in
two conformations or to exist in two different orientations in
the outer membrane. This could modify the higher-ordered
disulfide interactions in the outer membrane of the LGV
biovar and affect surface exposure of functionally important
domains. For example, following translocation, the LGV
proteins may form dimers in which one of the two amino-
terminal ends is not accessible for second-site cleavage. This
would explain the presence of equimolar quantities of
OMP2a and OMP20 in the outer membrane. Sequential
cleavage may also occur in trachoma strains, but because of
fundamental differences in structure between the LGV and
trachoma OMP2s, trachoma biovar OMP2s are all accessible
for second-site cleavage. Analogous OMP20 and OMP2,,
proteins are seen in C. psittaci (10). Conservation of OMP2
polymorphism between species which exhibit similar culture
infectivity characteristics but are otherwise highly divergent
(19) suggests that this mechanism may be important in
chlamydial virulence.
Delineation of the primary sequences of the serovar L2
OMP2 and the omp2L2 gene, as well as the availability of
cloned reagents, provides the basis for addressing questions
concerning the function and regulation of this protein.
Expression of this cloned gene in E. coli, alone or in
combination with other cloned genes, may allow a more
direct evaluation of potential function in host cell attach-
ment, endocytosis, or inhibition of lysosomal fusion. In
combination with the sequences for MOMP and the 15,000-
molecular-weight cysteine-rich protein, it may be possible to
derive structural models for the disulfide interactions in the
outer membrane. Partial sequence data reveal a cysteine-
rich open reading frame upstream of the omp2L2 gene, and
Northern (RNA) hybridization data indicate that the tran-
script for the omp2L2 gene is sufficiently large to encode an
additional protein (data not shown). These preliminary find-
ings suggest the possibility of an operon that encodes two
EB-specific, cysteine-rich outer-membrane proteins.
Most studies of antigen-specific antibody responses during
chlamydial infection have noted OMP2 as a major immuno-
reactive component (5, 6, 8, 21). These observations have
led to interest in the potential role of this antigen in both
immunologically mediated protection and pathogenicity. A
strong correlation between the immunogenicity of a peptide
and the tendency or ability to form a 1 turn has been
described (14). The frequency of 3 turns in OMP2 as
predicted by computer analysis may in part explain the
marked immunogenicity of this protein. The use of se-
quence-defined antigens derived from the cloned omp2L2
gene can be used to investigate these mechanisms at both the
B- and T-cell levels. In addition, Newhall et al. (21) have
proposed that this antigen may be a useful serodiagnostic
marker of infection. Cloned OMP2 antigens can be used for
this purpose without the potential problem of Fc binding
described for OMP1 (21).
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